Stocktoria
ImmunityBio, Inc. IBRX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-07-28
ImmunityBio, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| D. E. Shaw & Co., Inc. | 12,571,597 | $96.4M |
| BlackRock Finance, Inc. | 11,423,089 | $72.2M |
| CITADEL ADVISORS LLC | 5,135,878 | $39.4M |
| TWO SIGMA INVESTMENTS, LP | 4,385,500 | $33.6M |
| MILLENNIUM MANAGEMENT LLC | 1,444,044 | $11.1M |
| Point72 Asset Management, L.P. | 160,100 | $1.2M |
| AQR CAPITAL MANAGEMENT LLC | 66,547 | $510,415 |
Source: SEC EDGAR filings · CIK 0001326110 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.